In a viral study, mammalian galectin-9 was identified as a novel binding partner of Epstein-Barr virus latent membrane protein 1 (LMP1) from nasopharyngeal carcinomas (90). This evidence concerns the gene PDLIM7 and nasopharyngeal carcinoma.